Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 34, 2020 - Issue 6
304
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

New cytotoxic constituents in the water-soluble fraction from Momordicae Semen

, , , &
Pages 823-829 | Received 18 Jun 2018, Accepted 20 Jul 2018, Published online: 17 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hung-Tse Huang, Yu-Chi Lin, Li-Jie Zhang, Chia-Ching Liaw, Hsin-Yen Chen, Ming-Tung Hsueh & Yao-Haur Kuo. (2021) Anti-Inflammatory and anti-proliferative oleanane-type triterpene glycosides from the vine of Momordica cochinchinensis. Natural Product Research 35:16, pages 2707-2714.
Read now

Articles from other publishers (2)

Li-Xia Wang, Hong-Liang Wang, Jiao Huang, Tian-Zhe Chu, Cheng Peng, Hai Zhang, Hu-Lan Chen, Yong-Ai Xiong & Yu-Zhu Tan. (2022) Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications. Phytochemistry 202, pages 113326.
Crossref
Long Cheng, Yan Wang, Jiawei Wang, Haibo Qin, Guangbiao Zhu & Lingsong Tao. (2022) Cytotoxic Action of Palladium-Based Compound on Prostate Stem Cells, Primary Prostate Epithelial Cells, Prostate Epithelial Cells, and Prostate Cell Lines. Journal of Healthcare Engineering 2022, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.